Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a global biopharmaceutical company that offers comprehensive solutions for the entire biopharmaceutical process, from R&D to production and distribution. With a strong focus on biotechnology, Celltrion aims to enhance patient care by expanding access to innovative biologics and has multiple biosimilars approved in the U.S.
Reference
Product
Technology
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is a preclinical stage biotech company focused on innovative multi-target drug development, particularly for complex diseases. Their flagship program involves a tetraspecific drug for NASH treatment, highlighting their commitment to advancing therapeutic options through cutting-edge research and technology.
Reference
Core business
ONEGENE BIOTECHNOLOGY
N-BIOTEK
Bucheon-si, South Korea
A
51-100 Employees
-
Key takeaway
N-BIOTEK is a leading company in life science and regenerative medicine, offering a comprehensive 'Stem Cell Total Solution' that includes specialized equipment, cleanroom construction, and technology consulting. Their expertise in stem cell culture technology positions them as a key player in the biotech industry.
Reference
Product
Stem Cell Isolation Package - Lab Equipment - N-BIOTEK
N-BIOTEK
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech specializes in transforming cancer immunotherapy, cellular engineering, and genome editing through its innovative Hydroporator® platform, which enables highly effective non-viral delivery of genetic materials and nanoparticles into primary cells. This technology supports advancements in microfluidic gene editing for cell therapy.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
BIORCHESTRA focuses on developing innovative RNA medicines and delivery systems that address significant unmet medical needs, particularly in neurodegenerative and rare diseases of the Central Nervous System. Their advanced technology enhances the targeted delivery of RNA therapeutics, offering hope for patients with neglected and incurable conditions.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform utilizes a hyper-scale AI engine to analyze nucleotide properties, aiming to enhance the development of gene therapies. Their focus on AI-driven decision support for biomedical care providers promises to improve patient outcomes and reduce costs in the emerging field of gene-based therapy.
Reference
Core business
Spidercore Inc.
ProCell Therapeutics
Seoul, South Korea
A
1-10 Employees
2005
Key takeaway
ProCell aims to become a leading company in the biopharmaceutical area, highlighting its focus on drug development and innovative technologies.
Reference
Service
프로셀테라퓨틱스
MITT,MTD,거대분자세포내전송기술보유,신약개발,바이오벤처기업,피투스킨,성장인자원료,기능성화장품,OEM,ODM
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has built a substantial bio big data infrastructure over the past 20 years, positioning itself as a leader in bioinformatics solutions.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
Medipost
Seongnam-si, South Korea
A
- Employees
-
Key takeaway
MEDIPOST is a key player in biotechnology, specializing in the commercialization of stem cell therapeutics. They have successfully launched CARTISTEM®, the world's first regulatory-approved allogeneic stem cell product, and are advancing research with their PNEUMOSTEM® product, currently in clinical trials for treating Bronchopulmonary Dysplasia.
Reference
Core business
The Future of Biotechnology
You can find information on the research and manufacturing of stem cell treatments, cord blood storage companies, health functional foods, investments, and corporate news.
Femtobiomed
Seongnam-si, South Korea
A
11-50 Employees
2011
Key takeaway
FEMTOBIOMED is focused on advancing targeted gene delivery through multiplexed cell therapeutics, highlighting its innovative approach in the biotech field.
Reference
Core business
FEMTOBIOMED
Technologies which have been searched by others and may be interesting for you:
A selection of suitable products and services provided by verified companies according to your search.
Service
Tissue Culture Lab
Go to product
The biotech industry in South Korea presents numerous key considerations for those interested in exploring its landscape. One important aspect is the regulatory environment, which is overseen by the Ministry of Food and Drug Safety. The country has established rigorous approval processes for biotechnology products, ensuring safety and efficacy, but these can also pose challenges for new entrants. Additionally, South Korea's focus on research and development, supported by strong government funding and initiatives, creates ample opportunities for innovation in areas such as pharmaceuticals, medical devices, and agricultural biotechnology. Understanding the competitive landscape is crucial, as South Korea hosts a mix of established firms and emerging startups. Collaborations between academia and industry are common, fostering a vibrant ecosystem for biotech research. Environmental concerns are increasingly relevant, particularly in terms of sustainable practices and the impact of biotechnology on ecosystems. As the global market for biotech continues to grow, South Korea positions itself as a key player, particularly in the Asia-Pacific region. Companies looking to enter this market should remain vigilant about international trends and local market dynamics, as well as the potential for exporting biotech innovations. Overall, a thorough grasp of these factors will provide a solid foundation for navigating the South Korean biotech sector effectively.
Some interesting numbers and facts about your company results for Biotech
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 20 |
| Amount of suitable service providers | 9 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2002 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Biotech
What are related technologies to Biotech?
Based on our calculations related technologies to Biotech are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Biotech?
Start-Ups who are working in Biotech are MxT Biotech
Which industries are mostly working on Biotech?
The most represented industries which are working in Biotech are Biotechnology, Other, Medical, Healthcare, IT, Software and Services
How does ensun find these Biotech Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.